Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis
Background: we aim to investigate attitudes toward vaccination, by analyzing empirical factors associated with vaccine acceptance in the Lazio region mpox vaccination (MpoxVax) campaign in Italy. Methods: all subjects who accessed to MpoxVax and signed the informed consent were prospectively enrolled in the MPOX-VAC Study and were asked to fill out an anonymous survey. Two endpoints were selected: ‘delayed acceptance’ and ‘early acceptance’, defined as access for vaccination >60 and ≤30 days from the vaccination campaign starting (VCS), respectively. Results: over the study period 1717 individuals underwent vaccination: 129 (7%) >60 [1588 (92.5%) ≤60] and 676 (60%) ≤30 days from VCS. A bisexual orientation, a lower education level and a worse perceived physical and mental health were associated with delayed access to vaccination. Being Pre-Exposure Prophylaxis (PrEP) users and, marginally, HIV positive, having a high perceived risk for mpox infection and reporting high-risk behaviors like the use of recreational drugs/chems, sex under the influence of drugs and/or alcohol and higher number of principal sexual partners, were associated with early access to vaccination. Conclusions: according to our data, risk awareness was a major determinant of early mpox vaccination acceptance. Conversely, worse perceived health status and a low educational level were critical factors associated with delayed vaccination..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Preprints.org - (2023) vom: 04. Dez. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| doi: |
10.20944/preprints202310.1395.v1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
preprintsorg041321766 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | preprintsorg041321766 | ||
| 003 | DE-627 | ||
| 005 | 20231204120402.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231026s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.20944/preprints202310.1395.v1 |2 doi | |
| 024 | 7 | |a 10.20944/preprints202310.1395.v1 |2 doi | |
| 035 | |a (DE-627)preprintsorg041321766 | ||
| 035 | |a (preprintsorg)10.20944/preprints202310.1395 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Del Duca, Giulia |e verfasserin |0 (orcid)0009-0004-3408-3817 |4 aut | |
| 245 | 1 | 0 | |a Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background: we aim to investigate attitudes toward vaccination, by analyzing empirical factors associated with vaccine acceptance in the Lazio region mpox vaccination (MpoxVax) campaign in Italy. Methods: all subjects who accessed to MpoxVax and signed the informed consent were prospectively enrolled in the MPOX-VAC Study and were asked to fill out an anonymous survey. Two endpoints were selected: ‘delayed acceptance’ and ‘early acceptance’, defined as access for vaccination >60 and ≤30 days from the vaccination campaign starting (VCS), respectively. Results: over the study period 1717 individuals underwent vaccination: 129 (7%) >60 [1588 (92.5%) ≤60] and 676 (60%) ≤30 days from VCS. A bisexual orientation, a lower education level and a worse perceived physical and mental health were associated with delayed access to vaccination. Being Pre-Exposure Prophylaxis (PrEP) users and, marginally, HIV positive, having a high perceived risk for mpox infection and reporting high-risk behaviors like the use of recreational drugs/chems, sex under the influence of drugs and/or alcohol and higher number of principal sexual partners, were associated with early access to vaccination. Conclusions: according to our data, risk awareness was a major determinant of early mpox vaccination acceptance. Conversely, worse perceived health status and a low educational level were critical factors associated with delayed vaccination. | ||
| 700 | 1 | |a Tavelli, Alessandro |4 aut | |
| 700 | 1 | |a Mastrorosa, Ilaria |0 (orcid)0000-0003-1944-662X |4 aut | |
| 700 | 1 | |a Aguglia, Camilla |4 aut | |
| 700 | 1 | |a Lanini, Simone |0 (orcid)0000-0002-6743-4001 |4 aut | |
| 700 | 1 | |a Brita, Anna Clelia |4 aut | |
| 700 | 1 | |a Gagliardini, Roberta |4 aut | |
| 700 | 1 | |a Vita, Serena |4 aut | |
| 700 | 1 | |a Vergori, Alessandra |0 (orcid)0000-0001-6944-0686 |4 aut | |
| 700 | 1 | |a Paulicelli, Jessica |4 aut | |
| 700 | 1 | |a Natalini, Giorgia |4 aut | |
| 700 | 1 | |a D'Urso, Angela |4 aut | |
| 700 | 1 | |a Piselli, Pierluca |0 (orcid)0000-0002-7342-0263 |4 aut | |
| 700 | 1 | |a Gallì, Paola |4 aut | |
| 700 | 1 | |a Mondillo, Vanessa |4 aut | |
| 700 | 1 | |a Mastroianni, Claudio |0 (orcid)0000-0002-1286-467X |4 aut | |
| 700 | 1 | |a Tamburrini, Enrica |4 aut | |
| 700 | 1 | |a Sarmati, Loredana |4 aut | |
| 700 | 1 | |a Stingone, Cristof |4 aut | |
| 700 | 1 | |a Lichtner, Miriam |0 (orcid)0000-0002-7730-3953 |4 aut | |
| 700 | 1 | |a Nicastri, Emanuele |0 (orcid)0000-0002-5606-8712 |4 aut | |
| 700 | 1 | |a Farinella, Massimo |4 aut | |
| 700 | 1 | |a Leserri, Filippo |4 aut | |
| 700 | 1 | |a Siddu, Andrea |4 aut | |
| 700 | 1 | |a Maggi, Francesco |4 aut | |
| 700 | 1 | |a D'Arminio Monforte, Antonella |0 (orcid)0000-0003-0073-1789 |4 aut | |
| 700 | 1 | |a Vairo, Francesco |4 aut | |
| 700 | 1 | |a Barca, Alessandra |4 aut | |
| 700 | 1 | |a Vaia, Francesco |4 aut | |
| 700 | 1 | |a Girardi, Enrico |0 (orcid)0000-0001-8182-5896 |4 aut | |
| 700 | 1 | |a Mazzotta, Valentina |0 (orcid)0000-0002-0240-7504 |4 aut | |
| 700 | 1 | |a Antinori, Andrea |0 (orcid)0000-0003-2121-4684 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Preprints.org |g (2023) vom: 04. Dez. |
| 773 | 1 | 8 | |g year:2023 |g day:04 |g month:12 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/vaccines11121761 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.20944/preprints202310.1395.v1 |z kostenfrei |3 Volltext |
| 912 | |a preprintsorg | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 04 |c 12 | ||